[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@pfizer_news Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::540233480.png) @pfizer_news Pfizer Inc.

Pfizer Inc. posts on X about biontech, acquisition, momentum, cest the most. They currently have XXXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::540233480/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::540233480/c:line/m:interactions.svg)

- X Week XXXXX +141%
- X Month XXXXXX +162%
- X Months XXXXXX +2,918%
- X Year XXXXXX +53%

### Mentions: X [#](/creator/twitter::540233480/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::540233480/c:line/m:posts_active.svg)

- X Week X +17%
- X Month X +60%
- X Months X +200%
- X Year XX -XX%

### Followers: XXXXXX [#](/creator/twitter::540233480/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::540233480/c:line/m:followers.svg)

- X Week XXXXXX +0.08%
- X Month XXXXXX +0.31%
- X Months XXXXXX +0.36%
- X Year XXXXXX -XXXX%

### CreatorRank: undefined [#](/creator/twitter::540233480/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::540233480/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::540233480/influence)
---

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance) 

**Social topic influence**
[biontech](/topic/biontech), [acquisition](/topic/acquisition), [momentum](/topic/momentum), [cest](/topic/cest)
### Top Social Posts [#](/creator/twitter::540233480/posts)
---
Top posts by engagements in the last XX hours

"The @US_FDA has approved Pfizer and BioNTech SEs 2025-2026 COVID-19 #vaccine. Learn more about this announcement:"  
[X Link](https://x.com/pfizer_news/status/1960752925371756639) [@pfizer_news](/creator/x/pfizer_news) 2025-08-27T17:15Z 33.8K followers, 1529 engagements


"Today Pfizer & @BioNTech_Group announced positive top line results from an ongoing non-pivotal Phase X study evaluating the safety tolerability and immunogenicity of our COVID-19 Vaccine 2025-2026 Formula. Learn more about these results:"  
[X Link](https://x.com/pfizer_news/status/1965007534835511429) [@pfizer_news](/creator/x/pfizer_news) 2025-09-08T11:01Z 33.8K followers, 5644 engagements


"Announced today our proposed acquisition of Metsera has the potential to serve as an important growth driver for Pfizer as we work to deliver innovative therapeutic options in key areas such as obesity and cardiometabolic disease to patients in need"  
[X Link](https://x.com/pfizer_news/status/1970086749398614401) [@pfizer_news](/creator/x/pfizer_news) 2025-09-22T11:24Z 33.8K followers, 4463 engagements


"At #ESMO25 were highlighting the momentum of our extensive Oncology portfolio to redefine the cancer care continuum across 45+ abstracts with XX oral/mini oral presentations. Learn more:"  
[X Link](https://x.com/pfizer_news/status/1971166180212654100) [@pfizer_news](/creator/x/pfizer_news) 2025-09-25T10:53Z 33.8K followers, XXX engagements


"#BreakingNews: Today Pfizer announced a historic and voluntary agreement with@POTUS that will ensure American patients pay lower prices for their prescription medicines. With this agreement in place we can invest even more boldly in the U.S. fueling growth creating jobs and returning manufacturing home. Learn more about this announcement:"  
[X Link](https://x.com/pfizer_news/status/1973067416771973299) [@pfizer_news](/creator/x/pfizer_news) 2025-09-30T16:48Z 33.8K followers, XXX engagements


"Encouraging news for the HER2+ metastatic #BreastCancer community: Our Phase X trial demonstrated improved progression-free survival with a new investigational combination for first-line maintenance. Learn more:"  
[X Link](https://x.com/pfizer_news/status/1978050334103605660) [@pfizer_news](/creator/x/pfizer_news) 2025-10-14T10:48Z 33.8K followers, 3622 engagements


"At #ESMO25 were presenting updated overall survival data from our Phase X study of a targeted combination therapy in patients with metastatic non-small cell #LungCancer (NSCLC) with a BRAF V600E mutation. Stay tuned for the presentation on Sunday 10/19 at 8:30 am CEST"  
[X Link](https://x.com/pfizer_news/status/1979155432665919854) [@pfizer_news](/creator/x/pfizer_news) 2025-10-17T12:00Z 33.8K followers, XXX engagements


"At #ESMO25 were sharing final overall survival data from a Phase X study in men with a form of non-metastatic hormone-sensitive prostate cancer (nmHSPC). Learn more about the research which was also simultaneously published in the New England Journal of Medicine: Among men with this form of nmHSPC the risk of developing metastatic disease is high so early intervention with effective therapy is critical. These data show the potential of our therapy to make a meaningful impact and offer new hope for men facing #ProstateCancer"  
[X Link](https://x.com/pfizer_news/status/1979857585420308644) [@pfizer_news](/creator/x/pfizer_news) 2025-10-19T10:30Z 33.8K followers, XXX engagements


"At #ESMO25 we're presenting positive event-free survival and overall survival results in cisplatin-ineligible patients with muscle-invasive #BladderCancer from a Phase X trial with @AstellasUS and @Merck. Learn more:"  
[X Link](https://x.com/pfizer_news/status/1979557020991627511) [@pfizer_news](/creator/x/pfizer_news) 2025-10-18T14:35Z 33.8K followers, XXX engagements


"Today at #ESMO25 we presented updated overall survival data from our Phase X study of a targeted combination therapy in patients with metastatic non-small cell #LungCancer (NSCLC) with a BRAF V600E mutation. Learn more:"  
[X Link](https://x.com/pfizer_news/status/1979849848657502450) [@pfizer_news](/creator/x/pfizer_news) 2025-10-19T09:59Z 33.8K followers, XXX engagements


"At #ESMO25 new health-related quality-of-life data that complement previously reported efficacy results from a Phase X study for our CDK4/6 inhibitor in HR+ HER2+ advanced #BreastCancer will be presented"  
[X Link](https://x.com/pfizer_news/status/1979880207990272505) [@pfizer_news](/creator/x/pfizer_news) 2025-10-19T12:00Z 33.8K followers, XXX engagements